Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Otorhinolaryngology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    June 2022

  1. Erratum to "Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study".
    Cancer. 2022 Jun 24. doi: 10.1002/cncr.34358.
    PubMed    


  2. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
    Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2022;128:2193-2204.
    PubMed     Abstract available


    May 2022
  3. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    PubMed     Abstract available


  4. NELSON TJ, Thompson CA, Zou J, Kumar A, et al
    Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database.
    Cancer. 2022;128:1948-1957.
    PubMed     Abstract available


    April 2022
  5. HUTCHESON KA, Barbon CEA, Alvarez CP, Warneke CL, et al
    Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
    Cancer. 2022;128:1458-1466.
    PubMed     Abstract available


    March 2022
  6. PARK S, Oh D, Choi YL, Chi SA, et al
    Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Cancer. 2022 Mar 23. doi: 10.1002/cncr.34176.
    PubMed     Abstract available


  7. SOO J, Jin MC, Beadle BM, Holsinger FC, et al
    Circulating tumor DNA in head and neck cancer: Early successes and future promise.
    Cancer. 2022 Mar 17. doi: 10.1002/cncr.34189.
    PubMed     Abstract available


    February 2022
  8. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available


  9. OLIVER JR, Persky MJ, Wang B, Duvvuri U, et al
    Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Cancer. 2022;128:685-696.
    PubMed     Abstract available


  10. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    PubMed     Abstract available


    December 2021
  11. LIANG L, Liu Z, Zhu H, Wang H, et al
    Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Cancer. 2021 Dec 15. doi: 10.1002/cncr.34074.
    PubMed     Abstract available


  12. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    PubMed    


  13. AGGARWAL P, Hutcheson KA, Garden AS, Mott FE, et al
    Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
    Cancer. 2021;127:4470-4480.
    PubMed     Abstract available


    October 2021
  14. TREISTER NS, Brennan MT, Sollecito TP, Schmidt BL, et al
    Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Cancer. 2021 Oct 19. doi: 10.1002/cncr.33948.
    PubMed     Abstract available


  15. REN J, Pang W, Hueniken K, Haddad G, et al
    Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33936.
    PubMed     Abstract available


  16. FAKHRY C, Tewari SR, Zhang L, Windon MJ, et al
    RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
    Cancer. 2021;127:3523-3530.
    PubMed     Abstract available


    September 2021
  17. FOSTER CC, Couey MA, Kochanny SE, Khattri A, et al
    Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.
    Cancer. 2021 Sep 21. doi: 10.1002/cncr.33780.
    PubMed     Abstract available


  18. MEIJER AJM, Li KH, Brooks B, Clemens E, et al
    The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
    Cancer. 2021 Sep 7. doi: 10.1002/cncr.33848.
    PubMed     Abstract available


  19. BROCK PR
    New insights into cisplatin ototoxicity.
    Cancer. 2021 Sep 7. doi: 10.1002/cncr.33847.
    PubMed     Abstract available


  20. ABDELMEGUID AS, Hanna EY
    Reply to Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3265.
    PubMed    


  21. PANDA S, Raveendran S, Kumar R, Thakar A, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3264.
    PubMed    


  22. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    PubMed     Abstract available


  23. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    PubMed     Abstract available


    August 2021
  24. SEAMAN AT, Seligman KL, Nguyen KK, Al-Qurayshi Z, et al
    Characterizing head and neck cancer survivors' discontinuation of survivorship care.
    Cancer. 2021 Aug 30. doi: 10.1002/cncr.33888.
    PubMed     Abstract available


  25. HARDMAN JC, Tikka T, Paleri V
    Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
    Cancer. 2021 Aug 19. doi: 10.1002/cncr.33800.
    PubMed     Abstract available


  26. GUO TW, Saiyed F, Yao CMKL, Kiong KL, et al
    Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Cancer. 2021;127:2916-2925.
    PubMed     Abstract available


  27. CHERA BS, Sheth SH, Patel SA, Goldin D, et al
    Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33789.
    PubMed     Abstract available


  28. AMIT M, Liu C, Mansour J, Gleber-Netto FO, et al
    Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33773.
    PubMed     Abstract available


  29. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    PubMed     Abstract available


    July 2021
  30. YU KJ, Hsu WL, Chiang CJ, Chen TC, et al
    Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33799.
    PubMed     Abstract available


  31. TRENDOWSKI MR, Baedke JL, Sapkota Y, Travis LB, et al
    Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33775.
    PubMed     Abstract available


  32. VAN DIJK LV, Mohamed ASR, Ferrarotto R, McCoy LA, et al
    The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
    Cancer. 2021;127:2453-2464.
    PubMed     Abstract available


  33. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    PubMed     Abstract available


  34. LIU Z, Li H, Yu KJ, Xie SH, et al
    Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.
    Cancer. 2021 Jul 7. doi: 10.1002/cncr.33552.
    PubMed     Abstract available


    June 2021
  35. WITHROW DR, Devesa SS, Deapen D, Petkov V, et al
    Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33553.
    PubMed     Abstract available


  36. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    PubMed     Abstract available


  37. SABA NF
    Preoperative chemotherapy for sinonasal squamous cell carcinoma (SNSCC): Time to move closer to a definitive answer.
    Cancer. 2021;127:1734-1735.
    PubMed    


  38. ABDELMEGUID AS, Teeramatwanich W, Roberts DB, Amit M, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
    Cancer. 2021;127:1788-1795.
    PubMed     Abstract available


    May 2021
  39. RUAN X, Liang JH, Pan Y, Cai R, et al
    Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study.
    Cancer. 2021 May 27. doi: 10.1002/cncr.33626.
    PubMed     Abstract available


  40. XIAO C, Beitler JJ, Peng G, Levine ME, et al
    Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer. 2021 May 24. doi: 10.1002/cncr.33641.
    PubMed     Abstract available


  41. JUNG YS, Seok J, Hong S, Ryu CH, et al
    The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population.
    Cancer. 2021;127:1638-1647.
    PubMed     Abstract available


  42. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    PubMed     Abstract available


    April 2021
  43. DAHLSTROM KR, Song J, Thall PF, Fuller CD, et al
    Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
    Cancer. 2021;127:1228-1237.
    PubMed     Abstract available


  44. CHEN Y, Chang ET, Liu Q, Cai Y, et al
    Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study.
    Cancer. 2021 Apr 6. doi: 10.1002/cncr.33536.
    PubMed     Abstract available


  45. THOMAS GR
    Racial disparity in head and neck cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33555.
    PubMed    


  46. VOORA RS, Kotha NV, Kumar A, Qiao EM, et al
    Association of Race and Health Care System With Disease Stage and Survival in Veterans With Larynx Cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33557.
    PubMed     Abstract available


  47. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    PubMed     Abstract available


    March 2021
  48. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available


    February 2021
  49. DE BREE R, de Keizer B
    Comparison of different diagnostic approaches in the management of the clinically negative neck in early oral cancer patients.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33443.
    PubMed    


  50. NOEL CW, Forner D, Goldstein DP, Metser U, et al
    Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33446.
    PubMed     Abstract available


  51. KIONG KL, Yao CMKL, Lin FY, Bell D, et al
    Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33471.
    PubMed     Abstract available


  52. SHEWALE JB, Pickard RKL, Xiao W, Jiang B, et al
    Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33440.
    PubMed     Abstract available


  53. WANG SM, Freedman ND, Katki HA, Matthews C, et al
    Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.
    Cancer. 2021 Feb 22. doi: 10.1002/cncr.33427.
    PubMed     Abstract available


  54. LYDIATT WM
    Head and neck cancer staging: Balancing innovation with consistency.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33415.
    PubMed    


  55. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    PubMed     Abstract available


  56. PRINTZ C
    Study adds evidence to link between gum disease and cancer risk: Researchers observe connection with gastric, esophageal cancer.
    Cancer. 2021;127:495-496.
    PubMed    


    January 2021
  57. YAO CMKL, Fu S, Tam S, Kiong KL, et al
    Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers.
    Cancer. 2021 Jan 20. doi: 10.1002/cncr.33402.
    PubMed     Abstract available


  58. LIN YT, Wang HC, Tsai MH, Su YY, et al
    Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma.
    Cancer. 2021 Jan 6. doi: 10.1002/cncr.33391.
    PubMed     Abstract available


    December 2020

  59. Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.
    Cancer. 2020 Dec 21. doi: 10.1002/cncr.33320.
    PubMed     Abstract available


  60. AMIT M, Liu C, Gleber-Netto FO, Kini S, et al
    Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33373.
    PubMed     Abstract available


    November 2020
  61. KAWASAKI M, Ikeda Y, Ikeda E, Takahashi M, et al
    Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer.
    Cancer. 2020 Nov 6. doi: 10.1002/cncr.33316.
    PubMed     Abstract available


    October 2020
  62. MORGAN RL, Eguchi MM, McDermott J, Mueller AC, et al
    Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer.
    Cancer. 2020 Oct 29. doi: 10.1002/cncr.33244.
    PubMed     Abstract available


  63. LIU W, Qdaisat A, Ferrarotto R, Fuller CD, et al
    Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation.
    Cancer. 2020 Oct 21. doi: 10.1002/cncr.33283.
    PubMed     Abstract available


  64. SWIECICKI PL, Bellile EL, Brummel CV, Brenner JC, et al
    Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33226.
    PubMed     Abstract available


  65. ZHANG N, Li Y, Chang X, Lei F, et al
    Long-term effectiveness of one-time endoscopic screening for esophageal cancer: A community-based study in rural China.
    Cancer. 2020;126:4511-4520.
    PubMed     Abstract available


  66. ZAKERI K, Rotolo F, Lacas B, Vitzthum LK, et al
    Predictive classifier for intensive treatment of head and neck cancer.
    Cancer. 2020 Oct 5. doi: 10.1002/cncr.33212.
    PubMed     Abstract available


    June 2020
  67. BROUGHMAN JR, Xiong DD, Moeller BJ, Contrera KJ, et al
    Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
    Cancer. 2020;126:2784-2790.
    PubMed     Abstract available


  68. LANG KUHS KA, Wood CB, Wiggleton J, Aulino JM, et al
    Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
    Cancer. 2020;126:2658-2665.
    PubMed     Abstract available


    April 2020
  69. BIGELOW EO, Blackford AL, Eytan DF, Eisele DW, et al
    Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
    Cancer. 2020;126:1793-1803.
    PubMed     Abstract available


  70. FULLERTON ZH, Butler SS, Mahal BA, Muralidhar V, et al
    Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
    Cancer. 2020;126:1424-1433.
    PubMed     Abstract available


  71. OLIVER JR, Lieberman SM, Tam MM, Liu CZ, et al
    Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma.
    Cancer. 2020;126:1413-1423.
    PubMed     Abstract available


    March 2020
  72. WILSON CL, Brinkman TM, Cook C, Huang S, et al
    Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort.
    Cancer. 2020;126:1330-1338.
    PubMed     Abstract available


  73. ZHAN KY, Puram SV, Li MM, Silverman DA, et al
    National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1295-1305.
    PubMed     Abstract available


    January 2020
  74. FREITAG J, Wald T, Kuhnt T, Gradistanac T, et al
    Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2020;126:1856-1872.
    PubMed     Abstract available


  75. RODEN DF, Hobelmann K, Vimawala S, Richa T, et al
    Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Cancer. 2020;126:1873-1887.
    PubMed     Abstract available


  76. FAN M, Kang JJ, Lee A, Fan D, et al
    Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
    Cancer. 2020;126:1905-1916.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: